# Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone

> **NCT07038408** · NA · RECRUITING · sponsor: **Ceric Sàrl** · enrollment: 2256 (estimated)

## Conditions studied

- Drug Coated Balloon
- Bioresorbable Scaffold
- Percutaneous Coronary Intervention (PCI)
- Acute Coronary Syndrome (ACS)

## Interventions

- **PROCEDURE:** Angioplasty with DCB (bail-out BRS)
- **PROCEDURE:** Angioplasty with BRS

## Key facts

- **NCT ID:** NCT07038408
- **Lead sponsor:** Ceric Sàrl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-24
- **Primary completion:** 2028-11-30
- **Final completion:** 2032-03
- **Target enrollment:** 2256 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07038408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07038408, "Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07038408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*